drugset / Trial / NCT04711837

Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery

NCT04711837

Phase 3 Completed 255 enrolled Haisco-USA Pharmaceuticals, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multicenter, randomized, double-blinded, propofol-controlled, Phase 3 clinical study to evaluate the efficacy and safety of HSK3486 for induction of general anesthesia in adults undergoing elective surgery.

Timeline

Start
2021-02-11
Primary completion
2022-04-13
Completion
2022-04-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule
Comparator Propofol Small molecule

Indications

No indication recorded.